| |
|
|
|
|
|
The findings were consistent with a right-sided retinoblastoma, with concern for transscleral and optic nerve extension.
Given the findings and CT results, the patient was admitted for further evaluation. Upon further questioning of members of the patient's family, they reported feeling at times that the right pupil would "disappear" or "not be there," only to reappear later. They denied specifically the presence of a white or discolored pupil. There was no known family history of retinoblastoma or other childhood eye disease. The patient had 1 sibling who shared the same mother, but different
|
Company:
Date:
April 27, 2009
|
|
|
|
|
|
|
|
|
|
To get your bearings, visit this area of the Academy’s Web site. You will find it a good home base for learning about Maintenance of Certification and discovering tools and services that will help you through the process. Among its offerings you will find the following:
Basic information about MOC. Maintenance of Certification involves more than the American Board of Ophthalmology’s closed-book exam. This section of the Academy MOC Essentials site gives a clear overview of the requirements and provides a link to the ABO Web site for further information. It gives straightforward answers to ques
|
Company:
Date:
April 27, 2009
|
|
|
|
|
|
|
|
|
|
OBJECTIVE:To summarize pharmacy database studies of persistence with ocular hypotensives and review the literature of adherence with 2 additional classes of medication—antihypertensives and antihyperlipidemics— comparing methods used to analyze adherence in the 3 treatment areas.
DATA SOURCES: A search of MEDLINE (1990–2004) was conducted, using search terms designed to identify English-language articles describing adherence or persistence with any of the 3 drug classes of interest.
STUDY SELECTION AND DATA EXTRACTION: All articles identified through MEDLINE were reviewed and screened for us
|
Company:
Date:
April 27, 2009
|
|
|
|
|
|
|
|
|
|
The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.
The materials presented here were prepare
|
Company:
Date:
April 27, 2009
|
|
|
|
|
|
|
|
|
|
Authors and Disclosures
As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by th
|
Company:
Date:
April 27, 2009
|
|
|
|
|
|
|
|
|
|
Online CME/CE
|
Company:
Date:
April 27, 2009
|
|
|
|
|
|
|
|
|
|
This Webinar co-produced by ARUP addresses some key questions about effective lipid profiling in determining and managing CHD risk.
William Crowell, MD, medical director of the Division of Lipoprotein Disorders at the Presbyterian Center for Preventive Cardiology and Presbyterian Cardiovascular Institute, discusses whether lipids are the best analytic measures of lipoprotein particles and the CHD risk lipoproteins confer; the associations of qualitative and quantitative lipoprotein measures with CHD risk; whether the inter-correlations between lipids and lipoproteins affect associations with C
|
Company:
Date:
April 27, 2009
|
|
|
|
|
|
|
|
|
|
The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
|
Company:
Date:
April 27, 2009
|
|
|
|
|
|
|
|
|
|
Online CME/CE
|
Company:
Date:
April 27, 2009
|
|
|
|
|
|
|
|
|
|
Overview
Focusing Ophthalmology on Reframing Glaucoma Education (FORGE) II: Perimetry in the Diagnosis and Management of Glaucoma is a series of continuing medical education symposia with 8 regional events (Los Angeles, Boston, New York City, Philadelphia, Miami, San Francisco, Chicago and Washington, D.C.) and 1 national event (American Academy of Ophthalmology annual meeting in Las Vegas) between August 2006 and April 2007. This is the second year Vindico Medical Education has conducted the FORGE symposia series. The 2005 version focused on structure in managing glaucoma, while the 2006 vers
|
Company:
Date:
April 27, 2009
|
|
|
|
|
|